Specific deletion of PKM2 in inflammatory hepatic CXCR3+ Th17 cells has ability to reverse inflammatory vigor and non-alcoholic fatty liver disease severity (Moreno-Fernandez et al., 2021). The gene discussed is PKM; the disease is metabolic dysfunction-associated steatotic liver disease.